RA CAPITAL MANAGEMENT, L.P. Diversified Active

Location: Boston, MA

CIK: 0001346824 · Show all filings

Period: Q3 2013 (← Previous) (Next →)

Filing Date: Nov 14, 2013

Total Value: $958M (100.0% shares, 0.0% debt)

Holdings (39)

ACAD ACADIA PHARMACEUTICALS INC 15.1%
Value $144M Shares 5,250,000 Share Price $27.47 * Est. Cost/Share $13.77 Unrealized @ Report Date +51.8%
— DYAX CORP 7.5%
Value $71.47M Shares 10,418,379 Share Price $6.86 Est. Cost/Share $3.46 Unrealized @ Report Date —
— NOVAVAX INC 6.8%
Value $65.52M Shares 20,800,000 Share Price $3.15 Est. Cost/Share $2.24 Unrealized @ Report Date —
ACAD ACADIA PHARMACEUTICALS INC 5.8%
Value $55.91M Shares 2,035,510 Share Price $27.47 * Est. Cost/Share $13.77 Unrealized @ Report Date +51.8%
— THERAPEUTICSMD INC 5.1%
Value $48.43M Shares 16,528,641 Share Price $2.93 Est. Cost/Share $3.00 Unrealized @ Report Date —
INSM INSMED INC 4.9%
Value $46.57M Shares 2,983,319 Share Price $15.61 * Est. Cost/Share $10.68 Unrealized @ Report Date +18.9%
SGMO SANGAMO BIOSCIENCES INC 4.7%
Value $44.67M Shares 4,258,244 Share Price $10.49 * Est. Cost/Share $8.72 Unrealized @ Report Date +13.8%
— ACHILLION PHARMACEUTICALS IN 4.6%
Value $43.66M Shares 14,457,061 Share Price $3.02 Est. Cost/Share $5.68 Unrealized @ Report Date —
BCRX BIOCRYST PHARMACEUTICALS 4.4%
Value $42.55M Shares 5,844,700 Share Price $7.28 * Est. Cost/Share $5.07 Unrealized @ Report Date 0.0%
— NEWLINK GENETICS CORP 3.6%
Value $34.56M Shares 1,840,294 Share Price $18.78 Est. Cost/Share $19.72 Unrealized @ Report Date —
PRTA PROTHENA CORP PLC 3.5%
Value $33.31M Shares 1,646,399 Share Price $20.23 * Est. Cost/Share $15.16 Unrealized @ Report Date +16.7%
SGMO SANGAMO BIOSCIENCES INC 3.3%
Value $31.47M Shares 3,000,000 Share Price $10.49 * Est. Cost/Share $8.72 Unrealized @ Report Date +13.8%
— XOMA CORP DEL 3.2%
Value $31.05M Shares 6,915,525 Share Price $4.49 Est. Cost/Share $3.66 Unrealized @ Report Date —
— DERMA SCIENCES INC 2.6%
Value $24.7M Shares 1,994,876 Share Price $12.38 Est. Cost/Share $13.35 Unrealized @ Report Date —
— SUNESIS PHARMACEUTICALS INC 2.5%
Value $24.15M Shares 4,869,261 Share Price $4.96 Est. Cost/Share $5.18 Unrealized @ Report Date —
— KERYX BIOPHARMACEUTICALS INC 2.5%
Value $24.13M Shares 2,391,261 Share Price $10.09 Est. Cost/Share $7.47 Unrealized @ Report Date —
— HYPERION THERAPEUTICS INC 2.5%
Value $23.59M Shares 902,858 Share Price $26.13 Est. Cost/Share $22.00 Unrealized @ Report Date —
— CHEMOCENTRYX INC 1.8%
Value $16.93M Shares 3,045,380 Share Price $5.56 Est. Cost/Share $5.56 Unrealized @ Report Date —
— ACHILLION PHARMACEUTICALS IN 1.7%
Value $16.61M Shares 5,500,000 Share Price $3.02 Est. Cost/Share $5.68 Unrealized @ Report Date —
— BLUEBIRD BIO INC 1.3%
Value $12.6M Shares 467,418 Share Price $26.96 Est. Cost/Share $26.96 Unrealized @ Report Date —
— ROCKWELL MED INC 1.2%
Value $11.4M Shares 1,000,000 Share Price $11.40 Est. Cost/Share — Unrealized @ Report Date —
MYGN MYRIAD GENETICS INC 1.1%
Value $10.57M Shares 450,000 Share Price $23.50 * Est. Cost/Share $28.41 Unrealized @ Report Date 0.0%
OMER OMEROS CORP 1.1%
Value $10.29M Shares 1,055,311 Share Price $9.75 * Est. Cost/Share $4.61 Unrealized @ Report Date +29.3%
— KERYX BIOPHARMACEUTICALS INC 1.1%
Value $10.09M Shares 1,000,000 Share Price $10.09 Est. Cost/Share $7.47 Unrealized @ Report Date —
— AMPIO PHARMACEUTICALS INC 1.0%
Value $9.942M Shares 1,325,566 Share Price $7.50 Est. Cost/Share $7.50 Unrealized @ Report Date —
— NEWLINK GENETICS CORP 1.0%
Value $9.39M Shares 500,000 Share Price $18.78 Est. Cost/Share $19.72 Unrealized @ Report Date —
— ENZO BIOCHEM INC 0.9%
Value $8.437M Shares 3,348,029 Share Price $2.52 Est. Cost/Share $2.08 Unrealized @ Report Date —
— MIRATI THERAPEUTICS INC 0.9%
Value $8.359M Shares 551,723 Share Price $15.15 Est. Cost/Share $15.15 Unrealized @ Report Date —
— DYNAVAX TECHNOLOGIES CORP 0.7%
Value $7.14M Shares 6,000,000 Share Price $1.19 Est. Cost/Share $1.10 Unrealized @ Report Date —
— ONCOGENEX PHARMACEUTICALS IN 0.7%
Value $7.076M Shares 763,332 Share Price $9.27 Est. Cost/Share $9.80 Unrealized @ Report Date —
— CORONADO BIOSCIENCES INC 0.7%
Value $7.011M Shares 1,000,000 Share Price $7.01 Est. Cost/Share — Unrealized @ Report Date —
PTCT PTC THERAPEUTICS INC 0.7%
Value $6.438M Shares 300,000 Share Price $21.46 * Est. Cost/Share $17.38 Unrealized @ Report Date 0.0%
— ARROWHEAD RESH CORP 0.5%
Value $5.005M Shares 879,561 Share Price $5.69 Est. Cost/Share $2.00 Unrealized @ Report Date —
— DYAX CORP 0.4%
Value $3.43M Shares 500,000 Share Price $6.86 Est. Cost/Share $3.46 Unrealized @ Report Date —
TGTX TG THERAPEUTICS INC 0.3%
Value $3.024M Shares 600,000 Share Price $5.04 * Est. Cost/Share $6.12 Unrealized @ Report Date 0.0%
AGIO AGIOS PHARMACEUTICALS INC 0.2%
Value $1.957M Shares 70,000 Share Price $27.96 Est. Cost/Share $27.61 Unrealized @ Report Date 0.0%
— OCERA THERAPEUTICS INC 0.2%
Value $1.83M Shares 215,999 Share Price $8.47 Est. Cost/Share $8.47 Unrealized @ Report Date —
— EPIZYME INC 0.0%
Value $400K Shares 10,000 Share Price $40.00 Est. Cost/Share $28.13 Unrealized @ Report Date —
— SAVIENT PHARMACEUTICALS INC 0.0%
Value $193K Shares 1,000,000 Share Price $0.19 Est. Cost/Share $0.23 Unrealized @ Report Date —